Speakers

Tuesday, April 29, 2003

9:00 a.m. PT
Live question and answer session with Dr. Tune
11:00 a.m. PT
Treatment of Psychosis in the Elderly


Larry Tune, M.D., MAS
Chief of Psychiatry, Wesley Woods Center on Aging at Emory University
Professor, Department of Psychiatry, Emory University, Atlanta, Georgia


Biosketch:
Dr. Tune received his MD degree from the University of Virginia, performed his internship at the Albany Medical Center Hospital in Albany, New York, and completed residencies in both Psychiatry and Neurology at Johns Hopkins University School of Medicine. Dr. Tune is the Chief of the Division of Geriatric Psychiatry at the Wesley Woods Center on Aging at Emory University in Atlanta, Georgia. Dr. Tune is a Professor of Psychiatry and Behavioral Sciences at Emory University School of Medicine, Co-director of the Clinical Ethics Course, Emory University School of Medicine, and Director, Clinical Core, Emory University Alzheimer s Disease Center. Dr. Tune is active in clinical research, which involve investigations of pharmacologic treatment methods in both Alzheimer s patients and in elderly patients with idiopathic and organic psy-choses.


The Tuesday, May 20, 2003 has been moved to the date below:
There is NO GRAND ROUNDS on May 20, 2003.


Tuesday, June 10, 2003

9:00 a.m. PT
Live question and answer session with Dr. Potkin
11:00 a.m. PT
Clinical Effectiveness of Atypical Antipsychotics in Naturalistic Trials


Steven Potkin, M.D.
Director of Clinical Research, Department of Psychiatry & Human Behavior
Director of Brain Imaging Center University of California, Irvine


Biosketch:
Steven G. Potkin, M.D. is Professor in the Department of Psychiatry and Human Behavior at the University of California Irvine, Director of Clinical Research at the UCI Neuropsychiatric Center and the Robert R. Sprague Director of the Brain Imaging Center. He received his M.D. from Washington University in St. Louis. He completed his psychiatric residency and a 2-year post-doctoral fellowship in social sciences research at Duke University. He later was at the National Institute of Mental Health intramural program at St. Elizabeth Hospital.

Learning Objectives:
At the conclusion of this talk the audience should be able to:
  • Understand the efficacy of antipsychotic drugs on positive,
    negative, cognitive symptoms, and suicidality in patients
    with schizophrenia.
  • Understand the putative mechanisms of action of
    antipsychotic drugs.



Tuesday, June 24, 2003

9:00 a.m. PT
Live question and answer session with Dr. McGough
11:00 a.m. PT
Use of Atypical Antipsychotics in Children and Adolescents


James J. McGough, M.D.
Associate Professor of Clinical Psychiatry David Geffen School of Medicine at UCLA


Biosketch:
Dr. McGough is Associate Professor of Clinical Psychiatry and Director of Clinical Programs for ADHD at the David Geffen School of Medicine at UCLA. He attended the Duke University School of Medicine where he also completed a residency in Psychiatry. He completed a fellowship in Child and Adolescent Psychiatry at UCLA, where he has been a member of the faculty since 1994. Dr. McGough is board certified in Psychiatry, Child and Adolescent Psychiatry, and Addictions Psychiatry.

Learning Objectives:
At the conclusion of this talk the audience should be able to:

  • Review the scientific evidence base for use of antipsychotic medica-tions in children and adolescents.
  • Consider treatment algorithms employing antipsychotic medications in selected pediatric conditions.